Revised SPC: Spravato (esketamine) 28 mg nasal spray, solution

SPC notes new licence extension for treatment of adults with moderate to severe episode of major depressive disorder, as acute short-term treatment in conjunction with oral antidepressants, for the rapid reduction of depressive symptoms, which constitute a psychiatric emergency.

Source:

electronic Medicines compendium